Related references
Note: Only part of the references are listed.Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
Wujin Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Xi Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
Yiguang Wang et al.
NATURE MATERIALS (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?
Yuan Zhang et al.
MOLECULAR THERAPY (2012)
Differentially Charged Hollow Core/Shell Lipid-Polymer-Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
Jinjun Shi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
Lipid-based systemic delivery of siRNA
Yu-Cheng Tseng et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes
Yasuteru Urano et al.
NATURE MEDICINE (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Share Paper
